在不同类型的结质瘤中CTHRC1的表达,预后值和生物学功能:生物信息分析和实验验证
Xueping Shi1, Xi Zeng1, Rukai Jiao2
1Department of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, P.R. China.
Clinical Medicine Insights. Oncology
|June 19, 2024
概括
含有1 (CTHRC1) 的原三环重复与质瘤进展和预后不佳有关. 这项研究强调了CTHRC1作为质瘤分级,入侵和亚型的潜在生物标志物,为临床实用提供了新的见解.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 异常的原三螺旋重复含有1 (CTHRC1) 表达涉及到各种癌症,与患者预后不佳相关.
- 在质瘤中CTHRC1的确切临床意义仍然不充分理解.
研究的目的:
- 研究质瘤中CTHRC1的表达模式,预后价值和生物功能.
- 通过实验方法验证生物信息学发现.
主要方法:
- 生物信息学分析CTHRC1表达和质瘤中的临床数据.
- 实验验证使用免疫组织化学和西方布洛特.
- 对拷贝数变异和DNA甲基化分析.
- 基因本体学和KEGG通路丰富分析.
主要成果:
- CTHRC1的表达与质瘤世界卫生组织 (WHO) 的等级和侵袭程度正相关.
- 高CTHRC1表达在介质质瘤亚型中普遍存在,并与预后不佳相关.
- CTHRC1作为一个独立的预后因素,对低度质瘤 (LGGs) 和质母细胞瘤 (GBM) 有不同的影响.
- 确定了CTHRC1的独特免疫透模式和潜在的调节机制 (CNV,DNA甲基化).
- CTHRC1和相关基因参与细胞外基因函数和瘤信号通路.
结论:
- CTHRC1在质瘤中作为预后生物标志物具有显著的临床实用性.
- CTHRC1可以作为标记物来识别质瘤的中细胞亚型.
更多相关视频
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.6K
11:00Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection
Published on: June 23, 2023
981
相关概念视频
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
